We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMACR
1876
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$20.6K ﹤0.01%
37,000
MCAER
1877
DELISTED
Mountain Crest Acquisition Corp. III Right
MCAER
$20.5K ﹤0.01%
256,245
BSGAR
1878
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$20.5K ﹤0.01%
173,591
MOBBW
1879
Mobilicom Ltd Warrants
MOBBW
$2.83B
$19.7K ﹤0.01%
20,300
MSPR
1880
DELISTED
MSP Recovery Inc
MSPR
$19.6K ﹤0.01%
+3
New +$15.5K
ZH
1881
Zhihu
ZH
$279M
$19.5K ﹤0.01%
+2,500
New +$17.5K
AIMDW icon
1882
Ainos Warrants
AIMDW
$15.5K ﹤0.01%
25,000
CELZ icon
1883
Creative Medical Technology
CELZ
$7.46M
$15.2K ﹤0.01%
4,000
-4,889
-55% -$20.1K
KULR icon
1884
KULR Technology Group
KULR
$128M
$15.1K ﹤0.01%
+1,570
New +$19.4K
CDIO icon
1885
Cardio Diagnostics
CDIO
$4.91M
$14.4K ﹤0.01%
+452
New +$48.8K
BMAQR
1886
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
$14.2K ﹤0.01%
391,125
BRLIR
1887
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$14.1K ﹤0.01%
74,155
PYPD icon
1888
PolyPid
PYPD
$92.2M
$13.9K ﹤0.01%
667
+167
+33% +$4.32K
HHGCR
1889
DELISTED
HHG Capital Corporation Rights
HHGCR
$13.8K ﹤0.01%
125,000
RPID icon
1890
Rapid Micro Biosystems
RPID
$104M
$13.5K ﹤0.01%
11,959
+1,886
+19% +$4.57K
IVDAW icon
1891
Iveda Solutions Warrant
IVDAW
$53.9K
$13.3K ﹤0.01%
24,000
SIOX
1892
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$13.1K ﹤0.01%
30,000
AREBW
1893
DELISTED
American Rebel Holdings Warrants
AREBW
$11.6K ﹤0.01%
602
FNCH
1894
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$11.5K ﹤0.01%
796
SPPI
1895
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$11.2K ﹤0.01%
30,401
STSA
1896
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$10.8K ﹤0.01%
11,968
NXLIW
1897
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$7.46K ﹤0.01%
13,500
COMSW
1898
DELISTED
COMSovereign Holding Corp. Warrants
COMSW
$6.86K ﹤0.01%
96,000
CREXW
1899
DELISTED
Creative Realities, Inc. Warrant
CREXW
$6.33K ﹤0.01%
10,906
DRMAW icon
1900
Dermata Therapeutics Warrant
DRMAW
$14.1K
$4.91K ﹤0.01%
12,000

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.